학술논문

Dapagliflozin Protects H9c2 Cells Against Injury Induced by Lipopolysaccharide via Suppression of CX3CL1/CX3CR1 Axis and NF-κB Activity
Document Type
Article
Source
In: Current Molecular Pharmacology. (Current Molecular Pharmacology, October 2022, 15(6):862-869)
Subject
Language
English
ISSN
18744702
18744672